Techub News reports that the biopharmaceutical company Synaptogenix (NASDAQ: SNPX) listed on the US stock market has announced the purchase of TAO, with the specific purchase amount undisclosed. This is part of the company's recently announced financial strategy focused on artificial intelligence (AI) and machine learning in the crypto assets sector, and it will select BitGo to provide qualified custody, stake, and trading services for Synaptogenix's TAO assets.

TAO-5.25%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)